Dr. Stefan Oschmann, Vice President EFPIA; Vice Chairman of the Executive Board, Deputy CEO, Merck KGaA
Stefan Oschmann, born on July 25, 1957 in Würzburg, Germany, has been Vice Chairman of the Executive Board of Merck since January 2015. Prior to this he was responsible for Merck’s Pharma business as Member of the Executive Board from 2011 to 2014.
Before joining Merck, Stefan Oschmann worked for the Pharma company MSD. There he served most recently as President of Emerging Markets. His prior positions at MSD included Member of Senior Management and Corporate Officer with responsibility for the business in Europe, the Middle East, Africa and Canada, Senior Vice President in charge of Worldwide Human Health Marketing, as well as Vice President of Europe and the German business. Before that, Stefan Oschmann held various positions in Belgium, the Netherlands, Austria and eastern Europe.
Prior to joining MSD, Stefan Oschmann worked for the International Atomic Energy Agency IAEA from 1985 until 1987 and for the German Animal Health Federation (BfT) from 1987 to 1989, a member association of the German Chemical Industry Association (VCI).
Stefan Oschmann studied veterinary medicine at Ludwig-Maximilians-Universität in Munich from 1977 to 1982 and earned a doctorate there in 1985. He is married and has two children.